Microtubule Normalization in Schizophrenia and Alzheimer's Disease: A Convergent Framework Linking Supplements, Exercise, and Gamma Entrainment to Cytoskeletal Repair

The microtubule hypothesis of antipsychotic action proposes that cytoskeletal normalization, not dopamine D2 receptor blockade, constitutes the primary therapeutic mechanism in schizophrenia (Leicht, 2026). If this hypothesis is correct, it raises a practical question: can microtubule dynamics be normalized through non-pharmacological means? Here I present a convergent framework in which four commonly available supplements — N-acetylcysteine (NAC), magnesium, omega-3 fatty acids, and zinc — address distinct and complementary aspects of microtubule dysfunction: tubulin cysteine protection via glutathione restoration, GTP hydrolysis regulation at β-tubulin, tubulin/MAP gene expression upregulation, and BDNF-mediated microtubule stabilization, respectively. Each mechanism is supported by peer-reviewed evidence linking the specific supplement to microtubule biology. The framework is completed by physical exercise (driving hippocampal neurogenesis, endogenous BDNF amplification, and gray matter restoration) and 40 Hz gamma entrainment (providing coherent oscillatory reference signals to a system characterized by elevated spontaneous gamma noise). A two-level pathology model distinguishes between oscillatory dysfunction (addressable by the biochemical and frequency layers) and chronified structural damage (requiring long-term neuroplastic effects of exercise). The framework extends naturally to Alzheimer's disease prevention, where the same microtubule-protective stack maps onto tau-mediated cytoskeletal degeneration, with the critical distinction that glycine supplementation — potentially beneficial in schizophrenia's NMDA-hypofunction context — may be contraindicated in Alzheimer's due to preferential gating of excitotoxic extrasynaptic NMDA receptors. This paper provides no clinical recommendations but proposes a mechanistically coherent, empirically grounded research framework for microtubule-targeted intervention in two major neurodegenerative and neuropsychiatric conditions.